Presentations from June 13, 2017

Presentation Speaker
A Revised Analytical Strategy for MIST Philip R. Tiller
An FDA Perspective Safety Testing of Drug Metabolites in Drug development Zengjun (Alex) Xu
BMS MIST Strategy and Experience Griff Humphreys
Risk Assessment of Reactive Metabolites in Drug Discovery Mark Grillo
Uncommon Biotransformation Pathways Chandra Prakash